Bolton Securities’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
Bolton Securities's IBB Position: Q3 2026 in Review
Bolton Securities reduced its iShares Biotechnology ETF (IBB) stake by 0.25% in Q3 2026, selling an estimated $602 and leaving 1,205 shares worth $254K. The position accounts for 0.01% of the portfolio, ranked #809.
Bolton Securities first reported a position in IBB in Q1 2025 and has held it in 7 quarters since. The position peaked at $5.71M in Q1 2026. 1,030 funds tracked by Wall St. Rank hold IBB as of Q3 2026.
- Bolton Securities held 1,205 shares of iShares Biotechnology ETF worth $254K as of Q3 2026.
- Bolton Securities sold 3 iShares Biotechnology ETF shares in Q3 2026, an estimated $602.
- iShares Biotechnology ETF made up 0.01% of Bolton Securities's portfolio in Q3 2026, its #809 holding.
- Bolton Securities first reported a position in iShares Biotechnology ETF in Q1 2025 and has held it in 7 quarters since.
- Bolton Securities's iShares Biotechnology ETF position peaked at $5.71M in Q1 2026.
- 1,030 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.
Based on Bolton Securities's 13F filing for Q3 2026, filed 12 Nov 2026.